Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Parallel workflow for high-throughput (>1,000 samples/day) quantitative analysis of human insulin-like growth factor 1 using mass spectrometric immunoassay.

Oran PE, Trenchevska O, Nedelkov D, Borges CR, Schaab MR, Rehder DS, Jarvis JW, Sherma ND, Shen L, Krastins B, Schwenke DC, Reaven PD, Nelson RW.

PLoS One. 2014 Mar 24;9(3):e92801. doi: 10.1371/journal.pone.0092801. eCollection 2014. Erratum in: PLoS One. 2014;9(5):e95812. Lopez, Mary F [removed].

2.

Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1.

Niederkofler EE, Phillips DA, Krastins B, Kulasingam V, Kiernan UA, Tubbs KA, Peterman SM, Prakash A, Diamandis EP, Lopez MF, Nedelkov D.

PLoS One. 2013 Nov 21;8(11):e81125. doi: 10.1371/journal.pone.0081125. eCollection 2013.

3.

Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum.

Krastins B, Prakash A, Sarracino DA, Nedelkov D, Niederkofler EE, Kiernan UA, Nelson R, Vogelsang MS, Vadali G, Garces A, Sutton JN, Peterman S, Byram G, Darbouret B, Pérusse JR, Seidah NG, Coulombe B, Gobom J, Portelius E, Pannee J, Blennow K, Kulasingam V, Couchman L, Moniz C, Lopez MF.

Clin Biochem. 2013 Apr;46(6):399-410. doi: 10.1016/j.clinbiochem.2012.12.019. Epub 2013 Jan 8.

4.

Determination of beta-2 microglobulin levels in plasma using a high-throughput mass spectrometric immunoassay system.

Niederkofler EE, Tubbs KA, Gruber K, Nedelkov D, Kiernan UA, Williams P, Nelson RW.

Anal Chem. 2001 Jul 15;73(14):3294-9.

PMID:
11476228
5.

Development of quantitative mass spectrometric immunoassay for serum amyloid A.

Trenchevska O, Yassine HN, Borges CR, Nelson RW, Nedelkov D.

Biomarkers. 2016 Jul 22:1-9. [Epub ahead of print]

PMID:
27308834
6.

Clinical assays for quantitation of insulin-like-growth-factor-1 (IGF1).

Ketha H, Singh RJ.

Methods. 2015 Jun 15;81:93-8. doi: 10.1016/j.ymeth.2015.04.029. Epub 2015 Apr 30. Review.

PMID:
25937392
7.

Mass Spectrometric Immunoassay for the qualitative and quantitative analysis of the cytokine Macrophage Migration Inhibitory Factor (MIF).

Sherma ND, Borges CR, Trenchevska O, Jarvis JW, Rehder DS, Oran PE, Nelson RW, Nedelkov D.

Proteome Sci. 2014 Oct 14;12(1):52. doi: 10.1186/s12953-014-0052-3. eCollection 2014.

8.

Quantitative mass spectrometry evaluation of human retinol binding protein 4 and related variants.

Kiernan UA, Phillips DA, Trenchevska O, Nedelkov D.

PLoS One. 2011 Mar 30;6(3):e17282. doi: 10.1371/journal.pone.0017282.

9.

Quantitative mass spectrometric immunoassay of insulin like growth factor 1.

Nelson RW, Nedelkov D, Tubbs KA, Kiernan UA.

J Proteome Res. 2004 Jul-Aug;3(4):851-5.

PMID:
15359740
10.

Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling.

Tubbs KA, Kiernan UA, Niederkofler EE, Nedelkov D, Bieber AL, Nelson RW.

Anal Chem. 2006 May 15;78(10):3271-6.

PMID:
16689526
11.

High-throughput protein characterization using mass spectrometric immunoassay.

Kiernan UA, Tubbs KA, Gruber K, Nedelkov D, Niederkofler EE, Williams P, Nelson RW.

Anal Biochem. 2002 Feb 1;301(1):49-56.

PMID:
11811966
12.

An automated, high-throughput method for targeted quantification of intact insulin and its therapeutic analogs in human serum or plasma coupling mass spectrometric immunoassay with high resolution and accurate mass detection (MSIA-HR/AM).

Peterman S, Niederkofler EE, Phillips DA, Krastins B, Kiernan UA, Tubbs KA, Nedelkov D, Prakash A, Vogelsang MS, Schoeder T, Couchman L, Taylor DR, Moniz CF, Vadali G, Byram G, Lopez MF.

Proteomics. 2014 Jun;14(12):1445-56. doi: 10.1002/pmic.201300300. Epub 2014 May 14.

PMID:
24668948
13.

Nanoparticle-assisted MALDI-TOF MS combined with seed-layer surface preparation for quantification of small molecules.

Ho YC, Tseng MC, Lu YW, Lin CC, Chen YJ, Fuh MR.

Anal Chim Acta. 2011 Jul 4;697(1-2):1-7. doi: 10.1016/j.aca.2011.04.008. Epub 2011 Apr 16.

PMID:
21641411
14.

Quantification of serum apolipoproteins A-I and B-100 in clinical samples using an automated SISCAPA-MALDI-TOF-MS workflow.

van den Broek I, Nouta J, Razavi M, Yip R, Bladergroen MR, Romijn FP, Smit NP, Drews O, Paape R, Suckau D, Deelder AM, van der Burgt YE, Pearson TW, Anderson NL, Cobbaert CM.

Methods. 2015 Jun 15;81:74-85. doi: 10.1016/j.ymeth.2015.03.001. Epub 2015 Mar 9.

PMID:
25766926
15.

Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants.

Trenchevska O, Sherma ND, Oran PE, Reaven PD, Nelson RW, Nedelkov D.

J Proteomics. 2015 Feb 26;116:15-23. doi: 10.1016/j.jprot.2014.12.011. Epub 2014 Dec 27.

16.

Surface preparation strategies for improved parallelization and reproducible MALDI-TOF MS ligand binding assays.

Roth MJ, Maresh EM, Plymire DA, Zhang J, Corbett JR, Robbins R, Patrie SM.

ACS Appl Mater Interfaces. 2013 Jan;5(1):6-10. doi: 10.1021/am3024756. Epub 2012 Dec 24.

PMID:
23249094
17.

Targeted mass spectrometry analysis of the proteins IGF1, IGF2, IBP2, IBP3 and A2GL by blood protein precipitation.

Such-Sanmartín G, Bache N, Callesen AK, Rogowska-Wrzesinska A, Jensen ON.

J Proteomics. 2015 Jan 15;113:29-37. doi: 10.1016/j.jprot.2014.09.013. Epub 2014 Sep 30.

PMID:
25277046
18.

A semi-automated mass spectrometric immunoassay coupled to selected reaction monitoring (MSIA-SRM) reveals novel relationships between circulating PCSK9 and metabolic phenotypes in patient cohorts.

Gauthier MS, Pérusse JR, Awan Z, Bouchard A, Tessier S, Champagne J, Krastins B, Byram G, Chabot K, Garneau P, Rabasa-Lhoret R, Faubert D, Lopez MF, Seidah NG, Coulombe B.

Methods. 2015 Jun 15;81:66-73. doi: 10.1016/j.ymeth.2015.03.003. Epub 2015 Mar 11.

PMID:
25770357
19.

Quantitative detection of trace perfluorinated compounds in environmental water samples by Matrix-assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry with 1,8-bis(tetramethylguanidino)-naphthalene as matrix.

Cao D, Wang Z, Han C, Cui L, Hu M, Wu J, Liu Y, Cai Y, Wang H, Kang Y.

Talanta. 2011 Jul 15;85(1):345-52. doi: 10.1016/j.talanta.2011.03.062. Epub 2011 Apr 5.

PMID:
21645709
20.

Mass spectrometric immunoassay of intact insulin and related variants for population proteomics studies.

Oran PE, Jarvis JW, Borges CR, Sherma ND, Nelson RW.

Proteomics Clin Appl. 2011 Aug;5(7-8):454-9. doi: 10.1002/prca.201000112. Epub 2011 Jun 8.

Items per page

Supplemental Content

Write to the Help Desk